About Dianthus Therapeutics
We are a clinical-stage biotechnology company developing novel therapies for autoimmune disease.
What we do
We are a clinical-stage biotechnology company researching and developing novel antibody therapies, with a focus on improving outcomes for people living with autoimmune and inflammatory diseases.
We would rather explain things plainly than dress them up. If you have a question about what we do or how we do it, ask — we will give you a straight answer.
Our classification
For reference, this organisation operates under NAICS 541714 — Research and Development in Biotechnology. We mention it because it is the simplest way to describe, precisely, the category of work we do.
Details
- Dianthus Therapeutics, Inc.
- 7 Times Sq Fl 43, New York, NY 10036
- (929) 999-4055
- [email protected]
- Mon–Fri 9:00 AM–6:00 PM ET
- NAICS 541714
Talk to us
The fastest way to find out whether we are the right fit is to describe what you need.